Rivas Medical Weight Loss review

Weekly clinic care changes the comparison

Rivas Medical Weight Loss charges $115 a week for compounded semaglutide and $165 a week for compounded tirzepatide, including a weekly in-person provider visit, vitals, a weigh-in and medication. Using an average calendar month, those weekly charges work out to roughly $500 and $717. They are not $115 or $165 monthly subscriptions. The higher budget buys a different service from a prescription shipped after an online assessment, so the sensible comparison is both cost and the value of regular physical appointments.

The package totals are explicit: semaglutide costs $437 for four weeks or $1,242 for twelve; tirzepatide costs $627 or $1,782 for the same periods. Those are five- and ten-percent reductions from the weekly pay-as-you-go amounts. Four weeks is twenty-eight days, while twelve weeks is eighty-four days. Keeping the actual term visible matters when comparing a package with a calendar-month competitor or estimating a year's treatment. The compounded program is described as flat priced across doses rather than charging a separate escalation ladder.

Geography and attendance are part of the purchase

This model depends on reaching a clinic. Rivas has fifteen locations across Maryland and Virginia, and the $195 initial evaluation must be completed in person. The company calls that payment a lifetime membership but qualifies it with annual attendance: visit once a year and the initial charge is not repeated. Someone who expects interruptions should clarify how the rule applies after a long absence. Telehealth availability alongside the clinics does not mean a new patient can bypass the in-person starting requirement.

For a mother arranging childcare, work and transport, weekly appointments may be either useful structure or an expensive obligation that is hard to use. A nearby location and a realistic appointment schedule matter more than the number of clinics on a map. Ask what happens when a visit is missed, postponed or moved, and whether the package permits any flexibility. The value proposition is strongest when the patient can actually attend and wants recurring measured contact rather than the lightest possible remote service.

Keep the branded route and financial terms separate

Rivas also publishes a $100 monthly follow-up fee for a Wegovy or Zepbound prescription. That payment covers the visit and prescription service, not the brand-name medication; the pharmacy charge is separate and insurance may affect it. It should not be compared with the all-inclusive compounded weekly program as though both figures purchased the same thing. Obtain the pharmacy's own quote and the clinic fee together when considering a branded prescription, especially if insurance approval or the chosen dose could change the bill.

The practice accepts HSA and FSA payment and offers Cherry and CareCredit financing for packages. Financing changes payment timing rather than the underlying treatment price, and its separate agreement deserves attention. Rivas says there are no contracts and cancellation is available, but package refunds and missed-visit treatment still need a concrete explanation. No compounding pharmacy is named in the available information. The strongest reason to choose Rivas is accessible, frequent in-person care; the strongest reason to look elsewhere is a schedule, location or budget that makes those weekly visits difficult to sustain.